SCHEMBL10184102

SCHEMBL10184102

O=C1C(N(C(=O)CN2Cc3ccccc3C2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 4/20 0.37
▸ OPRM1 P35372 6/20 0.37
▸ OPRK1 P41145 5/20 0.37
▸ OPRL1 P41146 5/20 0.37
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CCKAR P32238 2/20 0.34
▸ CCKBR P32239 2/20 0.34
▸ AGTR2 P50052 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MMP9 P14780 2/20 0.33
▸ MMP1 P03956 1/20 0.33
▸ MMP3 P08254 1/20 0.33
▸ ADAM17 P78536 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183907 0.91 NPC1 (0.35) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183330 0.88 IDH1 (0.48) IDH1OPRM1OPRK1OPRL1HTR1A
SCHEMBL10185674 0.88 IDH1 (0.48) IDH1OPRM1OPRK1OPRL1HTR1A
SCHEMBL10183299 0.87 OPRM1 (0.40) IDH1OPRM1OPRK1OPRL1CCKAR
SCHEMBL10185657 0.86 IDH1 (0.47) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183337 0.86 OPRM1 (0.39) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183319 0.86 MEN1 (0.43) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10185708 0.84 LMNA (0.41) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183782 0.84 OPRM1 (0.40) IDH1OPRM1OPRK1OPRL1CCKAR
SCHEMBL10183928 0.84 IDH1 (0.36) IDH1OPRM1OPRK1OPRL1CCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback